Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach

被引:109
作者
Evangelou, E
Kyzas, PA [1 ]
Trikalinos, TA
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
[2] Tufts Univ New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
关键词
podoplanin; D2-40; specificity; Bayesian inference; lymphangiogenesis;
D O I
10.1038/modpathol.3800457
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Tumor lymphatic density is evaluated by means of specific lymphatic endothelium markers, and is a potential predictor of clinically meaningful outcomes. There are many claims on the postulated superiority of some of these markers to identify lymphatics, always in the absence of quantitative data. We therefore compared the diagnostic accuracy of the antibody against podoplanin and the commercially available D2-40, employing Bayesian statistics to account for the absence of a gold standard. We used the pan-endothelial marker CD34 to identify 23 542 distinct blood and lymphatic vessels in sections from 30 formalin-fixed, paraffin-embedded archival tissue blocks of head and neck squamous cell carcinoma specimens. We stained two adjacent sections with podoplanin and D2-40 and identified the continuum of each stained vessel in the sections with a comprehensive method. Overall, 1864 vessels were stained with both markers, 119 only with podoplanin and 391 only with D2-40. Significantly more vessels with intraluminal red blood cells were stained with D2-40 compared to podoplanin ( McNemar's P<0.0001). Both antibodies had extremely high specificity (99.7% (95% credible interval (CrI): 99.5 - 99.9%) and 98.8% ( 95% CrI: 98.3 - 99.5%) for podoplanin and D2-40, respectively) and very high sensitivity (92.6% ( 95% CrI: 86.1 - 97.9%) and 97.3% ( 95% CrI: 94.9 - 99.2%) for podoplanin and D2-40, respectively). Inferences were qualitatively similar when we took into account in the analyses the possibility that the two tests ( antibodies) may be correlated. We calculated that 96.3% ( 95% CrI: 94.2 - 98.6%) of the vessels stained with podoplanin and 88.9% ( 95% CrI: 83.9 - 95.7%) of the vessels stained with D2-40 were truly lymphatics. These numbers were in agreement with the observed number of stained vessels without intraluminal red blood cells. Our results suggest that both antibodies are excellent lymphatic endothelium markers and that there may be little reason to prefer either of them in most settings.
引用
收藏
页码:1490 / 1497
页数:8
相关论文
共 36 条
[1]  
Beasley NJP, 2002, CANCER RES, V62, P1315
[2]  
Birner P, 2001, CLIN CANCER RES, V7, P93
[3]   Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium [J].
Breiteneder-Geleff, S ;
Soleiman, A ;
Kowalski, H ;
Horvat, R ;
Amann, G ;
Kriehuber, E ;
Diem, K ;
Weninger, W ;
Tschachler, E ;
Alitalo, K ;
Kerjaschki, D .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) :385-394
[4]  
BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141
[5]   Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression [J].
Choi, WWL ;
Lewis, MM ;
Lawson, D ;
Yin-Goen, QQ ;
Birdsong, GG ;
Cotsonis, GA ;
Cohen, C ;
Young, AN .
MODERN PATHOLOGY, 2005, 18 (01) :143-152
[6]   Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma [J].
Chu, AY ;
Litzky, LA ;
Pasha, TL ;
Acs, G ;
Zhang, PJ .
MODERN PATHOLOGY, 2005, 18 (01) :105-110
[7]   Lymphangiogenesis in malignant tumours: does it occur? [J].
Clarijs, R ;
Ruiter, DJ ;
de Waal, RMW .
JOURNAL OF PATHOLOGY, 2001, 193 (02) :143-146
[8]  
Cunnick GH, 2002, HISTOL HISTOPATHOL, V17, P863, DOI 10.14670/HH-17.863
[9]   Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests [J].
Dendukuri, N ;
Joseph, L .
BIOMETRICS, 2001, 57 (01) :158-167
[10]   Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix [J].
Dumoff, KL ;
Chu, C ;
Xu, XW ;
Pasha, T ;
Zhang, PJ ;
Acs, G .
MODERN PATHOLOGY, 2005, 18 (01) :97-104